Innovent Biologics announces the appointment of Dr. Samuel Zhang as its Global Chief Business Officer to oversee global strategy and business development for the company.
Dr. Zhang will report directly to Dr. Michael Yu, the founder, Chairman, and CEO of Innovent Biologics, indicating a crucial leadership structure within the organization.
The new Global Chief Business Officer will play a key role in advancing Innovent's initiatives in developing, manufacturing, and commercializing high-quality medicines across various therapeutic areas.
#innovent-biologics #dr-samuel-zhang #global-chief-business-officer #business-development #biopharmaceutical-industry
[
add
]
[
|
|
...
]